Your browser doesn't support javascript.
loading
Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma.
D'Alessio, Antonio; Cammarota, Antonella; Zanuso, Valentina; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza.
Afiliação
  • D'Alessio A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, (Milan), Italy.
  • Cammarota A; Medical Oncology and Hematology Unit,Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, (Milan), Italy.
  • Zanuso V; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, (Milan), Italy.
  • Pressiani T; Medical Oncology and Hematology Unit,Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, (Milan), Italy.
  • Personeni N; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, (Milan), Italy.
  • Rimassa L; Medical Oncology and Hematology Unit,Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, (Milan), Italy.
Expert Rev Anticancer Ther ; 21(9): 927-939, 2021 09.
Article em En | MEDLINE | ID: mdl-34167423
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article